Gumieniczek Anna, Owczarek Beata, Pawlikowska Bernadeta
Department of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.
Exp Diabetes Res. 2012;2012:653678. doi: 10.1155/2012/653678. Epub 2012 Mar 4.
The present study was undertaken to determine oxidative/nitrosative stress in aqueous humor of alloxan-induced hyperglycemic rabbits and to investigate the effects of two oral antidiabetic drugs, pioglitazone from peroxisome proliferator-activated receptor gamma (PPARγ) agonists and repaglinide from nonsulfonylurea K(ATP) channel blockers. Ascorbic acid (AA), glutathione (GSH), total antioxidant status (TAS), lipid peroxidation products (LPO), total nitrites (NO(2)), advanced oxidized protein products (AOPP), and protein carbonyl groups (PCG) were determined using respective colorimetric and ELISA methods. In our hyperglycemic animals, AA decreased by 77%, GSH by 45%, and TAS by 66% as compared to control animals. Simultaneously, LPO increased by 78%, PCG by 60%, AOPP by 84%, and NO(2) by 70%. In pioglitazone-treated animals, AA and TAS increased above control values while GSH and PCG were normalized. In turn, LPO was reduced by 54%, AOPP by 84%, and NO(2) by 24%, in relation to hyperglycemic rabbits. With repaglinide, AA and TAS were normalized, GSH increased by 20%, while LPO decreased by 45%. Our results show that pioglitazone and repaglinide differ significantly in their ability to ameliorate the parameters like NO(2), PCG, and AOPP. In this area, the multimodal action of pioglitazone as PPARγ agonist is probably essential.
本研究旨在测定四氧嘧啶诱导的高血糖兔房水中的氧化/亚硝化应激,并研究两种口服抗糖尿病药物的作用,一种是过氧化物酶体增殖物激活受体γ(PPARγ)激动剂吡格列酮,另一种是非磺酰脲类K(ATP)通道阻滞剂瑞格列奈。使用各自的比色法和酶联免疫吸附测定法测定了抗坏血酸(AA)、谷胱甘肽(GSH)、总抗氧化状态(TAS)、脂质过氧化产物(LPO)、总亚硝酸盐(NO₂)、晚期氧化蛋白产物(AOPP)和蛋白质羰基(PCG)。与对照动物相比,在我们的高血糖动物中,AA降低了77%,GSH降低了45%,TAS降低了66%。同时,LPO增加了78%,PCG增加了60%,AOPP增加了84%,NO₂增加了70%。在吡格列酮治疗的动物中,AA和TAS增加到高于对照值,而GSH和PCG恢复正常。相对于高血糖兔,LPO减少了54%,AOPP减少了84%,NO₂减少了24%。使用瑞格列奈时,则AA和TAS恢复正常,GSH增加了20%,而LPO减少了45%。我们的结果表明,吡格列酮和瑞格列奈在改善NO₂、PCG和AOPP等参数的能力上有显著差异。在这方面,吡格列酮作为PPARγ激动剂的多模式作用可能至关重要。